Inactivation of hMLH1 and hMSH2 by Promoter Methylation in Primary Non-Small Cell Lung Tumors and Matched Sputum Samples

Journal of Clinical Investigation - United States
doi 10.1172/jci200315475
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

DNA Methylation in Tumor and Matched Normal Tissues From Non-Small Cell Lung Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Population Carrier Frequency of hMSH2 and hMLH1 Mutations

British Journal of Cancer
Cancer ResearchOncology
2000English

A Critical Re-Assessment of DNA Repair Gene Promoter Methylation in Non-Small Cell Lung Carcinoma

Scientific Reports
Multidisciplinary
2014English

Clinicopathological Significance of DAPK Promoter Methylation in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Cancer Management and Research
Oncology
2018English

Mechanisms of P16INK4A Inactivation in Non Small-Cell Lung Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

The Clinicopathological Significance of hMLH1 Hypermethylation in Non-Small-Cell Lung Cancer: A Meta-Analysis and Literature Review

OncoTargets and Therapy
OncologyPharmacology
2016English

The Relationship Between Aberrant Methylation and Survival in Non-Small-Cell Lung Cancers

British Journal of Cancer
Cancer ResearchOncology
2004English

Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy